RNA interference and the Immune System

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

RNA interference is a newly discovered means by which we are able to turn off cancer-causing genes with high precision. However, it is difficult to get the drug to every cancer cell. Therefore we are designing and testing new RNA interference molecules that are able to alert the immune system to the presence of the cancer thus causing its elimination. This will prove to be a more effective cancer treatment than current therapies.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $580,949.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

RNA interference | anti-tumour agents | cancer | cervical cancer | gene therapy | immune system